Reflections On The Past For Investors Today: OrganiGram Holdings Inc. (NASDAQ: OGI)

OrganiGram Holdings Inc. (NASDAQ:OGI) does about 1.43M shares in volume on a normal day but saw 1834568 shares change hands in Monday trading. The company now has a market cap of 205.14M USD. Its current market price is $2.18, marking an increase of 2.83% compared to the previous close of $2.12. The 52 week high reached by this stock is $2.92 whilst the lowest price level in 52 weeks is $0.97.

OrganiGram Holdings Inc. (OGI) has a 20-day trading average at $2.21 and the current price is -25.34% off the 52-week high compared with 124.70% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.07 and its 200-day simple moving average is $1.57. If we look at the stock’s price movements over the week, volatility stands at 9.58%, which decreases to 9.26% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 50.49 to suggest the stock is neutral.

The consensus objective for the share price is $2.66, suggesting that the stock has a potential upside of 18.05% over the period.

OrganiGram Holdings Inc. (OGI) stock is up 5.83% over the week and 9.55% over the past month. Its price is 66.41% year-to-date and -13.49% over the past year.

The stock last released its quarterly earnings report for quarter ended 8/30/2023, with the company’s earnings per share (EPS) of -$0.09 above consensus estimates by $0.01. Expected sales for next quarter are $118.81 million, which analysts say will come at $118.81 million for the current fiscal year and next year at $118.81 million. In addition, estimates put the company’s current quarterly revenue at an average of $118.81 million.

To reach the target analysts have set, the stock logically needs to grow 18.05 percent from here.

Outstanding shares total 81.16M with insiders holding 34.74% of the shares and institutional holders owning 11.20% of the company’s common stock. The company has a return on investment of -101.76% and return on equity of -69.15%. The beta has a value of 1.05. Price to book ratio is 0.90 and price to sales ratio is 1.79.